Vimarsana
Biggest News Aggregation in the World

Page 8 - Low Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Low Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Low Dose Today - Breaking & Trending Today

Low-dose CBCT comparable for dental implant surgery - Vimarsana News

Low-dose CBCT comparable for dental implant surgery

Low-dose cone-beam CT (CBCT) yields statistically similar performance to standard-dose CBCT imaging protocols for CAD/CAM-guided dental implant surgery.

PDC*line Pharma Presents First Immunological Results From Phase I/II Trial With PDC*lung01 at ESMO-IO 2022 - Vimarsana News

PDC*line Pharma Presents First Immunological Results From Phase I/II Trial With PDC*lung01 at ESMO-IO 2022

Treatment with PDC*lung01 induces anti-tumor immune response in significant number of patients which appears to be enhanced by combination with pembrolizumab PDC*line Pharma, a clinical stage biotech

Cary awarded year two of lung cancer screening grant - Vimarsana News

Cary awarded year two of lung cancer screening grant

Cary Medical Center has received the second year of funding to increase awareness related to Low Dose CT Lung Cancer Screening. The award of $20,000 will help support a broad range of health information activities along with a professional education program in the spring of 2023.

Cureus | Renal Effects of High-Dose Versus Low-Dose Lisinopril in Patients With Diabetic Nephropathy - Vimarsana News

Cureus | Renal Effects of High-Dose Versus Low-Dose Lisinopril in Patients With Diabetic Nephropathy

Background The present study was conducted to assess the renal effects of high dose versus low dose lisinopril in patients with diabetic nephropathy. Methodology A prospective observational study was conducted at the Khyber Teaching Hospital, Peshawar, Khyber Pakhtunkhwa, Pakistan, between July 1, 2019, to January 1, 2020. Patients were divided into two groups. Group A patients were administered a low dose (5 mg per day) of Lisinopril and group B were administered a higher dose of therapy (20 mg/day) for three months. At the end of the study, baseline renal functions, electrolytes, and status ...

Source: cureus.com
Hot Topic - Low Dose Naltrexone treatment has proven to help with COVID 19 and Long COVID in The LDN Book 3. - Vimarsana News

Hot Topic - Low Dose Naltrexone treatment has proven to help with COVID 19 and Long COVID in The LDN Book 3.

2 chapters with information that could help save thousands if not millions of lives worldwide this winter for those suffering from COVID and Long COVID.